Belvedere Trading’s Agilon Health AGL Stock Holding History

Belvedere Trading’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-791	Closed	-$77.7K	–	833
2024 Q3	$77.7K	Buy	+791	New	+$102K	﹤0.01%	479

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Belvedere Trading's AGL Position: Q4 2024 in Review

Belvedere Trading sold out of Agilon Health (AGL) in Q4 2024, closing a stake of 791 shares — an estimated $77.7K sold.

Belvedere Trading first reported a position in AGL in Q3 2024 and held it in 1 quarter. The position peaked at $77.7K in Q3 2024. 184 funds tracked by Wall St. Rank hold AGL as of Q4 2024.

Belvedere Trading reported no remaining Agilon Health position as of Q4 2024 after selling out during the quarter.
Belvedere Trading sold 791 Agilon Health shares in Q4 2024, an estimated $77.7K.
Belvedere Trading first reported a position in Agilon Health in Q3 2024 and held it in 1 quarter.
Belvedere Trading's Agilon Health position peaked at $77.7K in Q3 2024.
184 funds tracked by Wall St. Rank held Agilon Health as of Q4 2024.

Based on Belvedere Trading's 13F filing for Q4 2024, filed 31 Jan 2025.